title: Nanotechnology for therapy and imaging of liver diseases.
abstract: Nanotechnology has been considered for the improved delivery of various therapeutic agents, including drugs and genes. Indeed, liposomes and nanoparticles equipped with homing devices for the targeting of receptors over-expressed on the hepatic tissue have improved the treatment of various liver diseases. In this review, various nanotechnology approaches employed for the treatment/imaging of liver disease, either in preclinical or in clinic are discussed.
authors.affiliation: Drug Delivery Technologies and Innovation, Pharmaceutical Sciences Department, Sanofi-aventis, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France.
authors.forename: L Harivardhan
authors.initials: LH
authors.lastname: Reddy
authors.forename: Patrick
authors.initials: P
authors.lastname: Couvreur
mesh_terms: D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000628:therapy; D003952:Diagnostic Imaging; D016503:Drug Delivery Systems; D006505:Hepatitis / Q000628:therapy; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis* / Q000628:therapy*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000628:therapy; D058185:Magnetite Nanoparticles; D036103:Nanotechnology
chemical_list: D058185:Magnetite Nanoparticles